{"Symbol": "EW", "AssetType": "Common Stock", "Name": "Edwards Lifesciences Corp", "Description": "Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring.", "CIK": "1099800", "Exchange": "NYSE", "Currency": "USD", "Country": "USA", "Sector": "LIFE SCIENCES", "Industry": "ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES", "Address": "ONE EDWARDS WAY, IRVINE, CA, US", "OfficialSite": "https://www.edwards.com", "FiscalYearEnd": "December", "LatestQuarter": "2024-12-31", "MarketCapitalization": "42746749000", "EBITDA": "1635900000", "PERatio": "30.17", "PEGRatio": "4.161", "BookValue": "16.99", "DividendPerShare": "None", "DividendYield": "None", "EPS": "2.34", "RevenuePerShareTTM": "9.1", "ProfitMargin": "0.767", "OperatingMarginTTM": "0.255", "ReturnOnAssetsTTM": "0.0826", "ReturnOnEquityTTM": "0.166", "RevenueTTM": "5439500000", "GrossProfitTTM": "4322000000", "DilutedEPSTTM": "2.34", "QuarterlyEarningsGrowthYOY": "0.071", "QuarterlyRevenueGrowthYOY": "0.094", "AnalystTargetPrice": "79.48", "AnalystRatingStrongBuy": "5", "AnalystRatingBuy": "10", "AnalystRatingHold": "17", "AnalystRatingSell": "1", "AnalystRatingStrongSell": "0", "TrailingPE": "30.17", "ForwardPE": "28.49", "PriceToSalesRatioTTM": "7.86", "PriceToBookRatio": "4.054", "EVToRevenue": "6.85", "EVToEBITDA": "21.62", "Beta": "1.149", "52WeekHigh": "95.25", "52WeekLow": "58.93", "50DayMovingAverage": "71.25", "200DayMovingAverage": "71.12", "SharesOutstanding": "585755000", "DividendDate": "None", "ExDividendDate": "None"}